Gamida Cell Ltd.
NASDAQ: GMDA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Abigail L. Jenkins
- Employees
- 143
- Headquarters
- Jerusalem, Israel
- IPO year
- 2018
- Market cap
- $4.3M
- Website
- https://www.gamida-cell.com
Loading GMDA…
Loading profile data…Frequently asked questions about GMDA
What does Gamida Cell Ltd. (GMDA) do?
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individual...
Where does GMDA trade?
Gamida Cell Ltd. (GMDA) trades on the NASDAQ Global Market.
What sector is GMDA in?
Gamida Cell Ltd. (GMDA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Gamida Cell Ltd.?
Abigail L. Jenkins is the chief executive officer of Gamida Cell Ltd. (GMDA).
Where is Gamida Cell Ltd. headquartered?
Gamida Cell Ltd. is headquartered in Israel.
Does GMDA pay a dividend?
Gamida Cell Ltd. (GMDA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GMDA go public?
Gamida Cell Ltd. (GMDA) completed its initial public offering in 2018.